Cargando…
Early Cardiac Function Monitoring for Detection of Subclinical Doxorubicin Cardiotoxicity in Young Adult Patients with Breast Cancer
PURPOSE: As doxorubicin cardiotoxicity is considered irreversible, early detection of cardiotoxicity and prevention of overt heart failure is essential. Although there are monitoring guidelines for cardiotoxicity, optimal timing for early detection of subclinical doxorubicin cardiotoxicity is still...
Autores principales: | Chung, Woo-Baek, Yi, Jeong-Eun, Jin, Jung Yeon, Choi, Yun-Seok, Park, Chan Seok, Park, Woo-Chan, Song, Byung Joo, Youn, Ho-Joong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706863/ https://www.ncbi.nlm.nih.gov/pubmed/23843850 http://dx.doi.org/10.4048/jbc.2013.16.2.178 |
Ejemplares similares
-
Candesartan and carvedilol for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
por: Lee, Myunhee, et al.
Publicado: (2021) -
Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity
por: Chung, Woo-Baek, et al.
Publicado: (2016) -
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
por: Planek, Maria Isabel Camara, et al.
Publicado: (2020) -
Assessment of Subclinical Doxorubicin-induced Cardiotoxicity in a Rat
Model by Speckle-Tracking Imaging
por: Kang, Yu, et al.
Publicado: (2017) -
Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
por: Li, Jieli, et al.
Publicado: (2020)